Kunkel Joachim - 05 Jul 2026 Form 4 Insider Report for Arteris, Inc. (AIP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Jul 2026, 16:22:40 UTC
Prior SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim

Key filing fact

Kunkel Joachim filed Form 4 for Arteris, Inc. (AIP) on 07 Jul 2026.

Key facts

  • This page summarizes Kunkel Joachim's Form 4 filing for Arteris, Inc. (AIP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Jul 2026, 16:22.

Change

  • Previous filing in this sequence was filed on 04 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001375414 Primary reporting owner

Kunkel Joachim

Relationship
Director
Address
C/O ARTERIS, INC., 900 E. HAMILTON AVE., SUITE 300, CAMPBELL
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim
Signature date
07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AIP transaction

Common Stock

Award

Transaction value
Shares
+365
Change %
+0.49%
Price
$0.000000*
Shares after
74,695
Date
05 Jul 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on July 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from May 20, 2026 through July 2, 2026, which was $39.28.

Footnote F2

The Reporting Person elected to defer the receipt of shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .